Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sino Medical Sciences TechnologySHSE:688108 -3.25%80 EBITDA Margin % is 22.41% as of Mar. 2026, which is 21% above its 10-year median of 18.45. GuruFocus rates SHSE:688108 with a GF Score™ of 80/100 and a GF Value™ of ¥20.42 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Sino Medical Sciences Technology ranks better than 71.17% on this metric.
Sino Medical Sciences Technology (SHSE:688108) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Sino Medical Sciences Technology EBITDA Margin % Related Terms
Sino Medical Sciences Technology EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sino Medical Sciences Technology EBITDA Margin % Chart
SHSE:688108 vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, Sino Medical Sciences Technology's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sino Medical Sciences Technology EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sino Medical Sciences Technology's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Sino Medical Sciences Technology's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sino Medical Sciences Technology (SHSE:688108) has a EBITDA Margin % of 22.41% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Sino Medical Sciences Technology and its competitors. This is 21% above median its historical median of 18.45. According to the industry distribution chart, Sino Medical Sciences Technology ranks #235 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 28.8%.
Is Sino Medical Sciences Technology's EBITDA Margin % too high?
Sino Medical Sciences Technology's current EBITDA Margin % of 22.41% is 21% above median its 10-year median of 18.45. The Medical Devices & Instruments industry median EBITDA Margin % is 7.48. Sino Medical Sciences Technology's value of 22.41% is 199.6% above this industry median. Based on the distribution chart, Sino Medical Sciences Technology ranks #235 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Sino Medical Sciences Technology has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sino Medical Sciences Technology's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sino Medical Sciences Technology ranks #235 out of 815 companies for EBITDA Margin %. This puts Sino Medical Sciences Technology in the upper half of its industry. The industry median EBITDA Margin % is 7.48. Sino Medical Sciences Technology's value of 22.41% is 199.6% above this benchmark. While the company's 10-year median is 18.45 vs. the industry median of 7.48, Sino Medical Sciences Technology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sino Medical Sciences Technology's current EBITDA Margin % of 22.41% is 199.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Sino Medical Sciences Technology and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sino Medical Sciences Technology's current EBITDA Margin % is 22.41%, which is 21% above median its own 10-year median of 18.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sino Medical Sciences Technology stock overvalued right now?
Based on GuruFocus' analysis, Sino Medical Sciences Technology (SHSE:688108) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥20.42, compared to a current price of ¥15.18 — trading 25.7% below its estimated fair value. The current EBITDA Margin % is 22.41%, which is 21% above median its 10-year median of 18.45 and 199.6% above the Medical Devices & Instruments industry median of 7.48. Sino Medical Sciences Technology's overall GF Score™ is 80/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Sino Medical Sciences Technology (SHSE:688108), the current EBITDA Margin % is 22.41% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sino Medical Sciences Technology (SHSE:688108) Overvalued in 2026?
Based on GuruFocus' analysis, Sino Medical Sciences Technology stock appears to be undervalued.
The current stock price of ¥15.18 is trading 25.7% below its estimated GF Value™ of ¥20.42.
GuruFocus considers Sino Medical Sciences Technology to be Modestly Undervalued.
Key valuation signals for SHSE:688108:
EBITDA Margin %: 22.41% (21% above median its 10-year median of 18.45)
GF Value™: ¥20.42 vs. price of ¥15.18 (25.7% below fair value)
Industry Position: 199.6% above the Medical Devices & Instruments median (#235 of 815)
No single metric tells the full story. See the SHSE:688108 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sino Medical Sciences Technology Business Description
Sino Medical Sciences Technology Inc is a China based company engaged in the research, development, production and sales of high-end interventional medical devices.
80GF Score
Get the complete analysis for SHSE:688108
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688108 has been successfully added to your 
